(R)-carnitine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Oral L-carnitine supplementation for 6 months significantly increased low-density lipoprotein cholesterol (LDL-C), triglycerides, total, free, and acyl carnitine levels, while it decreased alanine transaminase, acyl/free carnitine ratio, β₂-microglobulin, and skin AGE values.”
Quoted verbatim from Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.. - Study
- RCT
- Duration
- 6 months
- Dose
- 900 mg/day oral
- Population
- Hemodialysis patients with carnitine deficiency (total carnitine below 50 μmol/L), randomized to L-carnitine or control
Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.2013PMID:23909402Permalink
Keep reading
- Everything the graph holds on (R)-carnitine
- Every compound studied against LDL cholesterol
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5SA25QDN2SGJXVH5V81FGVZ